检索结果-南通市图书馆

Mechanism and pathobiologic implications of chfr promoter methylation in gastric carcinoma

World Journal of Gastroenterology 2008年第32期14卷 5000-5007页

作者： Yu-Jia Gao Yan Xin lian-Jun Zhang Jin Zhou The Fourth Laboratory of Cancer Institute & Department of Tumor Pathology of general Surgery Institute The First Affiliated Hospital of China Medical University Shengyang 110001 Liaoning Province China Department of Surgery and Internal Medicine Liaoning Tumor Hospital Shengyang 110042 Liaoning Province China

AIM： TO investigate the aberrant methylation of chfr promoter in human gastric cancer （GC） and its impact on the expression of chfr mRNA and protein, as well as its correlation with clinical and histological features of human GC. METHODS： Methylation-specific polymerase chain reaction （MSPCR） was used to detect the methylation status of chfr promoter in 20 primary GC samples and paired normal gastric mucosa. The chfr mRNA and protein expressions were investigated both by RT-PCR and by Western blotting. The chfr protein expression in 39 GC samples was immunohistochemically examined. RESULTS： The DNA methylation of the chfr gene was found in 9 of the 20 GC samples （45%） and the down-regulation of chfr mRNA and protein was significantly associated with the methylation status of the chfr gene （P = 0.006）. In 20 samples of corresponding non-neoplastic mucosa, no DNA methylation of the chfr gene was detected. The chfr gene methylation in poorly differentiated GC samples was significantly higher than that in well-differentiated GC samples （P = 0.014）. Moreover, the negative chfr protein expression rate in paraffin-embedded GC samples was 55.07% （38/69）, the positive rate in poorly differentiated GC samples was 36.73% （18/49）, which was significantly lower than 65.00% （13/20） in well-differentiated GC samples （X^2 = 4.586, P = 0.032）. CONCLUSION： Aberrant methylation of the chfr gene may be involved in the carcinogenesis and development of GC, and is the predominant cause of down-regulation or loss of chfr mRNA or protein expression. As aberrant methylation of chfr promoter is correlated with tumor differentiation, it may help to predict the prognosis of GC and chfr may become a novel target of gene therapy for GC in the future.

关键词： chfr gene Gastric carcinoma DNA methylation

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：